The Effect of Lateral Tilt on Ventilation Distribution in Lungs Assessed by Electrical Impedance Tomography
Keywords
Abstract
Description
In the monocentric, intervention, prospective, randomized study, the investigators will examine the effect of lateral tilting (routinely used in critical care) on the lung inhomogeneity that will be analyzed by electrical impedance tomography (EIT) in the unconscious patients with acute primary brain disease and artificial pulmonary ventilation. Two types of lateral tilting will be compared: manual positioning of body by nurse versus the bed tilting (15° lateral tilt, original company (LINET) and product brand name (Eleganza 5).
Dates
| Last Verified: | 05/31/2020 |
| First Submitted: | 01/08/2020 |
| Estimated Enrollment Submitted: | 01/16/2020 |
| First Posted: | 01/20/2020 |
| Last Update Submitted: | 06/09/2020 |
| Last Update Posted: | 06/10/2020 |
| Actual Study Start Date: | 06/30/2020 |
| Estimated Primary Completion Date: | 06/29/2023 |
| Estimated Study Completion Date: | 06/29/2023 |
Condition or disease
Intervention/treatment
Device: Lateral tilt bed
Other: Body positioning
Phase
Arm Groups
| Arm | Intervention/treatment |
|---|---|
| Experimental: Lateral tilt bed Bed tilting (15° lateral tilt, original product brand name LINET Eleganza 5) | Device: Lateral tilt bed 15° lateral tilt, original product brand name LINET Eleganza 5 |
| Experimental: Body positioning Manual positioning of body by nurse. | Other: Body positioning Manual positioning of body by nurse: left side, back, right side, using positioning pillows |
Eligibility Criteria
| Ages Eligible for Study | 18 Years To 18 Years |
| Sexes Eligible for Study | All |
| Accepts Healthy Volunteers | Yes |
| Criteria | Inclusion Criteria: - Primary brain disease - Hospitalization in Neurocenter, Neurointensive Care Unit - Age>18 years - Unconsciousness - Artificial pulmonary ventilation Exclusion Criteria: - Intracranial hypertension - History of primary lung disease - The terminal stage of the disease - Refractory hemodynamic instability |
Outcome
Primary Outcome Measures
1. Atelectasis/collapse [up to 24 weeks]
Secondary Outcome Measures
1. Evaluating oxygenation parameters [up to 24 weeks]
2. Evaluating hemodynamic parameters [up to 24 weeks]
3. Cost effectiveness measurement between two groups [up to 24 weeks]
4. Profiling pneumonia incidence [up to 24 weeks]
5. Comparing duration of stay in Neurocenter Neurointensive Care Unit [up to 24 weeks]
